MUSTANG BIO, INC. Retained Earnings
MUSTANG BIO, INC. (MBIO) had Retained Earnings of -$400.67 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-05
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$400.67M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$399.60M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$398.64M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$398.11M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$400.67M 10-Q · filed 2026-08-05 |
| 2026-03-31 | -$399.60M 10-Q · filed 2026-05-05 |
| 2025-12-31 | -$398.64M 10-Q · filed 2026-08-05 |
| 2025-09-30 | -$398.11M 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$397.64M 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$396.88M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$396.72M 10-K · filed 2026-03-19 |
| 2024-09-30 | -$395.77M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$394.36M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$386.16M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$380.97M 10-K · filed 2025-03-28 |
| 2023-09-30 | -$372.36M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$362.30M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$346.06M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$329.37M 10-K · filed 2024-03-11 |
| 2022-09-30 | -$309.74M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$290.74M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$271.64M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$251.84M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$231.79M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$214.79M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$200.43M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$185.47M 10-K · filed 2022-03-23 |
| 2020-09-30 | -$164.87M 10-Q · filed 2020-11-06 |
| 2020-06-30 | -$151.91M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$137.32M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$125.46M 10-K · filed 2021-03-24 |
| 2019-09-30 | -$109.25M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$99.08M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$88.68M 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$79.07M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$67.30M 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$59.78M 10-Q · filed 2018-08-13 |
| 2018-03-31 | -$54.69M 10-Q · filed 2018-05-14 |
| 2017-12-31 | -$48.41M 10-K · filed 2019-03-18 |
| 2017-09-30 | -$32.81M 10-Q · filed 2017-11-14 |
| 2017-06-30 | -$25.87M 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$20.34M 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$17.12M 10-K · filed 2018-03-29 |
| 2016-09-30 | -$8.37M 10-Q · filed 2016-11-14 |
| 2015-12-31 | -$4.47M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |